Elessent emerges from DuPont
Submitted by:
Andrew Warmington
A private equity consortium made up of BroadPeak Global, Asia Green Fund and Saudi Arabian
Huntsman to exit Textile Effects?
Submitted by:
Andrew Warmington
The Huntsman board of directors has authorised management to conduct a strategic review of the
Croda sells most of PTIC to Cargill
Submitted by:
Andrew Warmington
Croda has agreed to sell most of its Performance Technologies & Industrial Chemicals (PTIC) business
IMCD expands on three continents
Submitted by:
Andrew Warmington
Distributor IMCD has agreed to acquire Polychem, a Vienna-based supplier of chemical raw materials and
Antibody buy for Piramal
Submitted by:
Andrew Warmington
India-based CDMO Piramal Pharma has taken a 27.78% equity stake in Yapan Bio of Hyderabad
Financial buyer for JM Health business
Submitted by:
Andrew Warmington
Johnson Matthey (JM) has agreed to sell the majority of its Health business to Altaris
Sumitomo Chemical reorganises labs
Submitted by:
Andrew Warmington
Sumitomo Chemical is to start a full-scale study on reorganising three of its research laboratories
Seqens confirms changed ownership
Submitted by:
Andrew Warmington
CDMO Seqens has confirmed that its planned change of ownership has been completed, with SK
New R&D base for James Robinson
Submitted by:
Andrew Warmington
James Robinson Speciality Ingredients (JRSI) has launched a dedicated 186 m2 biotechnology R&D facility in
CEFIC releases CSS impact report
Submitted by:
Andrew Warmington
CEFIC has released the first in a series of studies about the likely impact of